$TBBK

Bancorp, Inc.

2
0
0
$220K
Egan Martin
0%
Med

Bancorp (TBBK) Q2 2026 Earnings Call Transcript

Bancorp (TBBK) discussed its Q2 2026 earnings call, citing fintech GDV growth of 22.5% YoY and fintech revenue growth of 21% YoY. The company raised full-year 2026 EPS guidance to $5.95 to $6.05, with Q4 2026 EPS guidance of $1.65 to $1.75 and 2027 EPS guidance of $8.10 to $8.30. It forecast $200M buybacks in 2026.

Egan Martin sold $220K of TBBK

Egan Martin (Chief Accounting Officer) sold 3,057 shares of Bancorp, Inc. (TBBK) at an average of $72.03 ($72.01–$72.07, $0.22M total) across 2 trades on 2026-08-06.

Why The Bancorp Stock Popped Again Today

The Bancorp (TBBK) shares rose nearly 7% on Monday after two analysts raised price targets following its Q2 earnings. Piper Sandler’s Manuel Navas lifted fair value to $86 from $70 and kept an overweight rating, citing guidance for double-digit EPS growth and ongoing share repurchases. Keefe, Bruyette & Woods raised its target to $79 from $77 and kept a buy-equivalent rating.

TBBK sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning TBBK (Bancorp, Inc.). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.

Recent TBBK coverage spans earnings, market movers and financial news.

In the last 30 days, TBBK insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($220K). The most active reporter was Egan Martin, Chief Accounting Officer, with 2 filings.

What's driving TBBK

  • Guidance increase plus explicit buyback assumptions and fintech growth metrics suggest a constructive earnings power narrative for TBBK.

    yahoo.com · Aug 8, 2026

  • This is a routine insider open-market sale with no 10b5-1 plan disclosed; it may slightly affect sentiment but is not a fundamental catalyst.

    SEC EDGAR · Aug 6, 2026

  • Street PT increases reinforce the market’s read-through from The Bancorp’s post-earnings guidance and capital return plan.

    fool.com · Aug 3, 2026

  • Guidance raise plus EPS beat is likely to support near-term sentiment and earnings multiple, with upside contingent on continued profitability execution.

    fool.com · Aug 1, 2026

  • Revenue miss with EPS beat suggests margin/profitability held up despite weaker top-line momentum, likely keeping near-term sentiment cautious.

    financialcontent.com · Jul 30, 2026

alphai scores every news story that mentions TBBK with an AI model for sentiment and relevance, and aggregates insider trades from Bancorp, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $TBBK

Score
$TBBKMedAI 8/10

Bancorp (TBBK) Q2 2026 Earnings Call Transcript

Bancorp (TBBK) discussed its Q2 2026 earnings call, citing fintech GDV growth of 22.5% YoY and fintech revenue growth of 21% YoY. The company raised full-year 2026 EPS guidance to $5.95 to $6.05, with Q4 2026 EPS guidance of $1.65 to $1.75 and 2027 EPS guidance of $8.10 to $8.30. It forecast $200M buybacks in 2026.

$TBBKMed

Why The Bancorp Stock Popped Again Today

The Bancorp (TBBK) shares rose nearly 7% on Monday after two analysts raised price targets following its Q2 earnings. Piper Sandler’s Manuel Navas lifted fair value to $86 from $70 and kept an overweight rating, citing guidance for double-digit EPS growth and ongoing share repurchases. Keefe, Bruyette & Woods raised its target to $79 from $77 and kept a buy-equivalent rating.

$TBBKMed

Why The Bancorp Stock Beat the Market on Friday

The Bancorp (TBBK) rose about 3.5% on Friday after its Q2 results showed a bottom-line beat and raised full-year GAAP earnings guidance. Revenue was $163.5M vs $166.7M expected. GAAP net income was under $60.7M, about $1.45/share. Full-year guidance increased to $5.95-$6.05/share.

$TBBKMed

Bancorp, Inc. (TBBK): Results of Operations and Financial Condition

Bancorp, Inc. (TBBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tbbk-20260730xexx991.htm EX-99.1 Document Exhibit 99.1 THE BANCORP REPORTS 2Q 2026 EPS OF $1.45, ROA OF 2.51%, AND ROE OF 34.7% DRIVEN BY STRONG GROWTH IN LOANS AND FINTECH FEES; CONTINUED IMPROVEMENT IN CREDIT AND COST EFFICIENCIES Second Quarter 2026 Highlights • Earn

The Bancorp (TBBK) Reports Earnings Tomorrow: What To Expect

The Bancorp (NASDAQ: TBBK) is set to report earnings tomorrow after the bell. Last quarter it reported $161.4 million in revenue, down 8% year on year, and missed analysts on net interest income and slightly on tangible book value per share. For this quarter, analysts expect revenue up 3.6% y/y. The average analyst price target is $73.67 versus $68.60.

$TBBKMed

Why The Bancorp Stock Surged Today

The Bancorp (NASDAQ: TBBK) shares rose nearly 8% on Thursday after Keefe, Bruyette & Woods upgraded the stock. Analyst Timothy Switzer raised his rating to “outperform” from “market perform,” citing The Bancorp’s shift toward third-party banking services and expectations it can meet management’s guidance, with potential for higher growth versus traditional peers.

$TBBKMed

TBBK (NASDAQ: TBBK) CMO sells 8,400 shares, retains 24,942

Bancorp, Inc.'s EVP & Chief Marketing Officer, Maria Wainwright, sold 8,400 shares of common stock on April 28, 2026, at an average price of $60.2405 per share. Following this open-market transaction, she directly retains 24,942 shares. The sale, detailed in a Form 4 filing, signals a net seller activity of 8,400 shares valued at approximately $506,020.

$TBBKMed

JPMorgan Chase & Co. Trims Stake in The Bancorp, Inc. $TBBK

JPMorgan Chase & Co. significantly reduced its stake in The Bancorp, Inc. (NASDAQ:TBBK) by 44.3% in the third quarter, leaving it with 141,250 shares valued at approximately $10.58 million. Despite this trimming, institutional ownership remains high at 96.22%. The Bancorp recently reported an EPS of $1.28, missing estimates, though revenue exceeded expectations.

Related tickers